Publications
Scientific Posters
FoRx Therapeutics presents its scientific work at leading international conferences.
FORX-428: Best-in-class PARG inhibitor with promising anti-tumor activity in preclinical cancer models
EORTC–NCI–AACR Molecular Targets and Cancer Therapeutics, Boston, USA, 2025
FORX-428: A novel, potent PARG inhibitor demonstrating strong anti-tumor activity in preclinical cancer models
EMBO Workshop, Cape Sounio, Greece, 2024
FORX-06-428 is a novel PARG inhibitor with potent anti-tumor efficacy in preclinical cancer models
AACR Annual Meeting, San Diego, USA 2024